joseph quinn
Cited by
Cited by
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
AC Naj, G Jun, GW Beecham, LS Wang, BN Vardarajan, J Buros, ...
Nature genetics 43 (5), 436-441, 2011
The ageing systemic milieu negatively regulates neurogenesis and cognitive function
SA Villeda, J Luo, KI Mosher, B Zou, M Britschgi, G Bieri, TM Stan, ...
Nature 477 (7362), 90-94, 2011
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
S Ray, M Britschgi, C Herbert, Y Takeda-Uchimura, A Boxer, K Blennow, ...
Nature medicine 13 (11), 1359-1362, 2007
Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression
M Manczak, TS Anekonda, E Henson, BS Park, J Quinn, PH Reddy
Human molecular genetics 15 (9), 1437-1449, 2006
Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial
JF Quinn, R Raman, RG Thomas, K Yurko-Mauro, EB Nelson, C Van Dyck, ...
Jama 304 (17), 1903-1911, 2010
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
Analysis of shared heritability in common disorders of the brain
V Anttila, B Bulik-Sullivan, HK Finucane, RK Walters, J Bras, L Duncan, ...
Science 360 (6395), 2018
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
Z Hong, M Shi, KA Chung, JF Quinn, ER Peskind, D Galasko, J Jankovic, ...
Brain 133 (3), 713-726, 2010
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
Lipid peroxidation in aging brain and Alzheimer’s disease
TJ Montine, MD Neely, JF Quinn, MF Beal, WR Markesbery, LJ Roberts II, ...
Free Radical Biology and Medicine 33 (5), 620-626, 2002
Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders
F Abdi, JF Quinn, J Jankovic, M McIntosh, JB Leverenz, E Peskind, ...
Journal of Alzheimer's Disease 9 (3), 293-348, 2006
Cerebrospinal fluid tau and β-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
CM Clark, S Xie, J Chittams, D Ewbank, E Peskind, D Galasko, JC Morris, ...
Archives of neurology 60 (12), 1696-1702, 2003
Effects of a γ-secretase inhibitor in a randomized study of patients with Alzheimer disease
ER Siemers, JF Quinn, J Kaye, MR Farlow, A Porsteinsson, P Tariot, ...
Neurology 66 (4), 602-604, 2006
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes
G Jun, AC Naj, GW Beecham, LS Wang, J Buros, PJ Gallins, JD Buxbaum, ...
Archives of neurology 67 (12), 1473-1484, 2010
Phase 2 safety trial targeting amyloid β production with a γ-secretase inhibitor in Alzheimer disease
AS Fleisher, R Raman, ER Siemers, L Becerra, CM Clark, RA Dean, ...
Archives of neurology 65 (8), 1031-1038, 2008
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
M Shi, J Bradner, AM Hancock, KA Chung, JF Quinn, ER Peskind, ...
Annals of neurology 69 (3), 570-580, 2011
An anatomical study of cholinergic innervation in rat cerebral cortex
FP Eckenstein, RW Baughman, J Quinn
Neuroscience 25 (2), 457-474, 1988
YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease
R Craig-Schapiro, RJ Perrin, CM Roe, C Xiong, D Carter, NJ Cairns, ...
Biological psychiatry 68 (10), 903-912, 2010
Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change …
PH Reddy, S McWeeney, BS Park, M Manczak, RV Gutala, D Partovi, ...
Human molecular genetics 13 (12), 1225-1240, 2004
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
M Shi, C Liu, TJ Cook, KM Bullock, Y Zhao, C Ginghina, Y Li, P Aro, ...
Acta neuropathologica 128 (5), 639-650, 2014
The system can't perform the operation now. Try again later.
Articles 1–20